SJS Investment Consulting
SPRB icon

SJS Investment Consulting’s Spruce Biosciences SPRB Stock Holding History

SJS Investment Consulting’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$826 Buy
+17
New +$861 ﹤0.01% 2588

Other funds holding SPRB

SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
Parkside Financial Bank & Trust
Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
Cassaday & Co Wealth Management
Cassaday & Co Wealth Management Mclean, Virginia $5.65B AUM 14.23% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SJS Investment Consulting's SPRB Position: Q3 2026 in Review

SJS Investment Consulting opened a new position in Spruce Biosciences (SPRB) in Q3 2026: 17 shares worth $826. The stake represents ﹤0.01% of the portfolio and ranks #2588 among its holdings.

9 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • SJS Investment Consulting held 17 shares of Spruce Biosciences worth $826 as of Q3 2026.
  • Spruce Biosciences was a new SJS Investment Consulting position in Q3 2026.
  • Spruce Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2588 holding.
  • 9 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.